Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11566068
APP PUB NO 20210040194A1
SERIAL NO

17070157

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to bispecific antibodies having activity against a vascular endothelial growth factor (VEGF) and an angiopoietin (ANG), and methods of making and using such bispecific antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDIMMUNE LIMITEDCAMBRIDGE CB2 0AA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cepeda, Mario A Winchester, US 4 1
Coffman, Karen Gaithersburg, US 4 1
Dimasi, Nazzareno Gaithersburg, US 30 338
Fleming, Ryan Gaithersburg, US 24 97
Gao, Changshou Gaithersburg, US 58 799
Leow, Ching Ching Gaithersburg, US 12 33
Schwartz, Mittelman Adrian Brookfield, US 5 1
Tsui, Ping Gaithersburg, US 50 263

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 31, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 31, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 31, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00